CONNECTICUT ANALYTICAL CORPORATION — Department of Defense SBIR Phase I: CBD212-003
CONNECTICUT ANALYTICAL CORPORATION — SBIR Phase I award from Department of Defense.
- Amount
- $166,652
- Agency
- Department of Defense · Office for Chemical and Biological Defense
- Program / Phase
- SBIR · Phase I
- Topic
- CBD212-003
- Solicitation
- 21.2
- NAICS
- —
- Place of performance
- CT
- Period
- 2021-12-01 → 2022-05-31
Description
The recent COVID-19 world pandemic demonstrates most effectively the urgent need for near real-time detection of ambient airborne pathogens. It has been demonstrated that electrospray ionization, utilized in many mass spectrometers today, has the unique ability to capture bioaerosols non-destructively out of the air for subsequent interrogation. This proposal leverages on this electrospray capture technology to develop a suitable portable device that can yield qualitative information about specific target pathogens.